Drug | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Retail The Market Buzz Your Environment

Eli Lilly Seeks to Cut Insulin Costs as Walmart Debuts Lower-Price Rival

Rebecca Urena06/29/2021

2644

Walmart introduced a less expensive version of analog insulin and Eli Lilly (NYSE: LLY) CEO David Ricks revealed it is ready for the competition. Walmart announced Tuesday that it...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Entera Bio Ltd. (NASDAQ: ENTX) Topline Phase 2 BMD Data for EB613

financial buzz06/23/2021

2175

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Entera Bio Ltd. Announces Positive Topline Phase 2 BMD Data for EB613” Entera Bio Ltd. (NASDAQ: ENTX) surged...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Genetic Technologies Limited (NASDAQ: GENE) Foundational Pharmacogenomic Patent

financial buzz06/11/2021

2364

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Genetic Technologies Limited Granted Foundational Pharmacogenomic Patent” Genetic Technologies Limited (NASDAQ: GENE) surged over 14% in premarket trading...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Biogen Receives FDA Approval for Alzheimer’s Drug

Rebecca Urena06/07/202106/07/2021

2619

On Monday, The Food and Drug Administration, approved Biogen’s (NASDAQ: BIIB) Alzheimer’s disease drug aducanumab. The medication, which delays the cognitive decline in patients with Alzheimer’s, is the first...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Stealth BioTherapeutics Corp. (NASDAQ: MITO) Orphan Drug Designation EMA

financial buzz06/02/2021

1985

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Stealth BioTherapeutics Corp. Surges Following Orphan Drug Designation from the European Medicines Agency” Stealth BioTherapeutics Corp. (NASDAQ: MITO)...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Annovis Bio Inc. (NASDAQ: ANVS) Releases Alzheimer’s, Parkinson’s Study Results

financial buzz05/21/2021

1891

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Annovis Bio Inc. On the Rise After Releasing Alzheimer’s, Parkinson’s Study Results” Annovis Bio Inc. (NASDAQ: ANVS) surged...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Reata Pharmaceuticals, Inc. (NASDAQ: RETA) FDA Requests Preliminary Drug Meeting

financial buzz05/19/2021

1873

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Reata Pharmaceuticals, Inc. Surges as FDA Requests Preliminary Drug Meeting” Reata Pharmaceuticals, Inc. (NASDAQ: RETA) surged over 13%...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Palisade Bio, Inc. (NASDAQ: PALI) FDA Grants Fast Track Designation for LB1148

financial buzz05/13/2021

2246

FinancialBuzz.com’s latest The Buzz Show: Palisade Bio, Inc. Announces FDA Fast Track Designation for its investigational drug LB1148” Palisade Bio, Inc. (NASDAQ: PALI) surged over 25% in premarket trading...

Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Begins Human Trial Testing Oral Drug Against Covid-19

Rebecca Urena03/23/202103/23/2021

1973

Pfizer (NYSE: PFE) announced Tuesday that it has commenced the clinical trial for an experimental oral antiviral Covid-19 drug. The pill is expected to be used at the first...

Biotechnology Healthcare Investing News Life Style Market News Retail The Market Buzz Your Environment

Rite Aid CEO Awaits ‘Chaotic’ Weeks Ahead Amid Vaccine Rollouts

Rebecca Urena01/12/202101/12/2021

2337

CEO of Rite Aid (NYSE: RAD) Heyward Donigan, said she believes retailers will be forced to take on a bigger role regarding the distribution of Covid-19 vaccines as the...

Tag: Drug

Eli Lilly Seeks to Cut Insulin Costs as Walmart Debuts Lower-Price Rival

“The Buzz” Show: Entera Bio Ltd. (NASDAQ: ENTX) Topline Phase 2 BMD Data for EB613

“The Buzz” Show: Genetic Technologies Limited (NASDAQ: GENE) Foundational Pharmacogenomic Patent

Biogen Receives FDA Approval for Alzheimer’s Drug

“The Buzz” Show: Stealth BioTherapeutics Corp. (NASDAQ: MITO) Orphan Drug Designation EMA

“The Buzz” Show: Annovis Bio Inc. (NASDAQ: ANVS) Releases Alzheimer’s, Parkinson’s Study Results

“The Buzz” Show: Reata Pharmaceuticals, Inc. (NASDAQ: RETA) FDA Requests Preliminary Drug Meeting

“The Buzz” Show: Palisade Bio, Inc. (NASDAQ: PALI) FDA Grants Fast Track Designation for LB1148

Pfizer Begins Human Trial Testing Oral Drug Against Covid-19

Rite Aid CEO Awaits ‘Chaotic’ Weeks Ahead Amid Vaccine Rollouts

ABOUT US

Tweets